Skip to main content

Table 4 Multivariate analysis of the metastatic lymph node ratios and the other clinico-pathological characteristics

From: Clinical implications of metastatic lymph node ratio in gastric cancer

Characteristics Hazard ratio 95% confidence interval P value
Sex (male vs. female)   0.731 0.469–1.138 0.166
Age (years old)   1.026 1.006–1.045 0.009
Tumor number   1.299 0.706–2.391 0.401
Location of tumor     
  Middle/Upper 2.612 0.601–11.361 0.200
  Lower/Upper 1.605 0.362–7.117 0.534
Maximum tumor diameter (cm)     
  2–4/≤ 2 3.841 1.317–11.208 0.014
  > 4/≤ 2 4.546 1.572–13.143 0.005
pT category     
  pT2/pT1 1.025 0.376–2.795 0.961
  pT3/pT1 2.687 0.979–7.325 0.055
  pT4/pT1 1.157 0.192–6.982 0.874
Histological type     
  G2/G1 2.163 1.086–4.308 0.028
  G3/G1 2.313 1.285–4.136 0.005
Histological growth pattern (expanding vs. infiltrative)   0.923 0.579–1.470 0.736
lymphatic vessel infiltrate (present vs. absent)   0.814 0.504–1.316 0.401
pN category     
  PN1/pN0 1.980 1.043–3.758 0.037
  pN2/pN0 2.987 1.138–7.841 0.026
  pN3/pN0 4.380 1.201–15.966 0.025
Metastatic lymph nodes ratio (%)     
  1–39/0 1.980 1.043–3.0785 0.037
  40–79/0 4.726 1.502–14.872 0.008
  80–100/0 11.841 2.787–50.321 0.001